USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Nuclera Nucleics Ltd.

USPTO PatentsView assignee record - 11 granted patents across 11 technology areas, active 2020–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B01L (CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE).

11
Total patents granted
11
CPC technology areas
16.2
Avg claims per patent
-
5-year filing velocity

The verdict

Nuclera holds 11 US patents across 11 technology areas, rank #24,903 of 50,000 tracked assignees.

#24,903
of 50,000 US assignees by volume
Top 14%
by Innovation Score (50.0/100)
16.2
avg claims per patent

Portfolio overview

Nuclera Nucleics Ltd. has been granted 11 US utility patents between 2020 and 2023, placing Nuclera Nucleics Ltd. at rank #24,903 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.2 claims per patent with primary concentration in B01L (CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE). As a Foreign Corporation, Nuclera Nucleics Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Nuclera sits between Northeast Petroleum University (11 patents, rank #24,899) and Obshchestvo S Ogranichennoy Otvetstvennostyu “ntlab-sc” (11 patents, rank #24,907) - the closest US assignees by grant volume. The composite Innovation Score of 50.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2020 through 2023, with 11 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Nuclera Nucleics Ltd.'s 16.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 11 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Nuclera Nucleics Ltd. against peers pursuing similar technology classes.

Who files at Nuclera's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Nuclera holds 11 patents at rank #24,903, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Nuclera's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

50 Top 14% higher than 86% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 202020222023 4
USPTO utility patent grants by year · 2020–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table
Nuclera Nucleics Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2020 1 9.1%
2022 6 54.5%
2023 4 36.4%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard

Where it ranks

Overall rank by patents

#24,903

Across all tracked assignees

Innovation Score

50.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Nuclera Nucleics Ltd. hold?
Nuclera Nucleics Ltd. holds 11 US granted patents filed between 2020 and 2023, spanning 11 technology areas.
What is Nuclera Nucleics Ltd.'s Innovation Score?
Nuclera Nucleics Ltd. has an Innovation Score of 50.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Nuclera Nucleics Ltd. focus on?
Nuclera Nucleics Ltd.'s top technology area is B01L (CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE) with 5 patents. The company has filed patents in 11 CPC subclasses total.
Is Nuclera Nucleics Ltd.'s patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Nuclera Nucleics Ltd..
What does claim depth mean for Nuclera Nucleics Ltd.'s patents?
Nuclera Nucleics Ltd.'s patents average 16.2 claims each. This falls within the standard range, providing solid legal coverage.
How is the Nuclera Nucleics Ltd. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Nuclera's 11 grants land it in the top 14% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Nuclera ranks #24,903 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in B01L - see who else leads that technology area. B01L leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.